$AVPT

TD Cowen maintains AvePoint at Buy, raises price target to $18 from $15

TD Cowen kept its Buy rating on AvePoint and increased its price target to $18 from $15, suggesting a 7.7% upside from the Nov 2 close of $16.71.

Original reporting
Published Nov 3, 2026, 3:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 3:39 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
TD Cowen maintains AvePoint at Buy, raises price target to $18 from $15 — source image
Decision brief

The 30-second read

$AVPTBullishLow
01

Why it matters

The main tradable element is sentiment around AvePoint, driven by the higher target and implied upside versus the referenced close.

02

Market read

This is a bullish analyst update for AvePoint, but it lacks new company fundamentals in the provided text.

03

What to watch

Traders may discount the update if the target change is largely mechanical or if upcoming AvePoint results could override analyst framing.

Relevance 4/10Novelty 4/10Timing: today’s analyst note update, no scheduled company event cited

Background

The article is an analyst action from TD Cowen: Buy maintained and price target increased.

Company-level read

Ticker impact

$AVPTBullishMedium confidence
Context

TD Cowen maintained AvePoint at Buy and raised its price target to $18 from $15, implying upside versus the Nov 2 close.

Expected impact

Likely modest upward bias as traders price in the higher target, with follow-through dependent on broader analyst/earnings catalysts.

Evidence & confidence

The article provides only an analyst rating and price-target change, with no new AvePoint operational or financial datapoint.

Market effects

Limited read-through to the broader software/IT services space because the piece is a single-bank target change, not sector guidance.

No specific regional market linkage beyond general US small/mid-cap sentiment.

Minimal global relevance; no international regulatory, deal, or macro catalyst mentioned.

Counterpoint

Price-target hikes often fade if they are not accompanied by new earnings, guidance, or material contract wins.

Key entities

  • AvePoint

    Subject of the analyst action, with Buy rating maintained and price target raised to $18 from $15.

Related articles

$AVPTHigh

Why is Avepoint stock rallying today?

Avepoint (AVPT) stock rose 4.1% after S&P Dow Jones Indices announced it will join the S&P SmallCap 600 index on November 2, replacing LXP Industrial Trust. The move is driven by expected buying from passive funds tracking the index. AVPT reached a 52-week high of $17.16, up 94% from its low.

$AVPTMedAI 9/10

AvePoint (AVPT) Q2 2026 Earnings Call Transcript

AvePoint (AVPT) reported Q2 2026 revenue of $124.5M, up 22% YoY, with SaaS revenue $98.5M (79% of total). Total ARR was $465.1M (+27%), net new ARR $29.9M, and GAAP operating margin 8.2%. Full-year guidance: ARR $522.1M-$528.1M and revenue $508.5M-$512.5M. The company also spent $50M on share repurchases in Q2.

$AVPTHighAI 9/10

AvePoint lifts annual recurring revenue guidance after Q2

AvePoint reported Q2 2026 revenue of $124.5M and raised full-year annual recurring revenue guidance. SaaS revenue was $98.5M, up 27% y/y, and ARR ended at $465.1M, up 27%. Q3 revenue is forecast at $128.2M to $130.2M, and full-year ARR at $522.1M to $528.1M. The company cited demand for AI governance.

$AVPTHigh

AvePoint Announces Second Quarter 2026 Financial Results

AvePoint, Inc. (AVPT) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 AvePoint Announces Second Quarter 2026 Financial Results Second quarter SaaS revenue of $98.5 million, representing 27% year-over-year growth, 26% on a constant currency basis Second quarter Total revenue of $124.5 million, representing 22% year-over-year growth, 21%